FDA Chides Sunovion Over Misstating Brovana Risks, Benefits

Sunovion Pharmaceuticals Inc. promoted its respiratory drug Brovana in a deceptive manner that buried discussion of risks in fine print and exaggerated effectiveness by suggesting the product would completely revitalize patients, the U.S. Food and Drug ...read more

  • Tags: